Ecosystem structure
Relevant categories, care pathways, technologies, business models, geographies, and stakeholder groups.
Ecosystem mapping
Digital Health Ecosystem Mapping
Build a decision-ready map of the organisations, relationships, capabilities, and signals shaping a defined digital health landscape.
The decision context
A market map should explain the ecosystem, not merely list companies
Digital health landscapes are shaped by interactions between ventures, providers, payors, biopharma, medical device companies, investors, regulators, research organisations, and technology platforms. A directory captures participants but misses the relationships and maturity signals that determine how the ecosystem works.
Galen Growth defines the landscape around a specific strategic question and maps the entities, categories, evidence, activity, and connections required to answer it.
What Galen Growth evaluates
Evidence organised around the decision
Company landscape
Venture maturity, differentiation, funding, evidence, partnerships, regulatory position, and strategic relevance.
Relationship networks
Connections among ventures, corporates, providers, investors, research institutions, and other ecosystem actors.
Momentum and gaps
Areas of concentrated activity, emerging capability, under-served need, and weak ecosystem infrastructure.
HealthTech Alpha evidence
A connected view of the global healthtech landscape
HealthTech Alpha applies a consistent digital health taxonomy to ventures and their market activity. That foundation allows Galen Growth to build custom ecosystem maps without relying on keyword lists, while retaining traceability to company, transaction, partnership, evidence, and regulatory records.
- Ontology-led market definition
- Venture and stakeholder segmentation
- Partnership and investor networks
- Maturity, evidence, and momentum signals
Methodology
From question to defensible action
- Define the boundary
Translate the strategic question into inclusion criteria covering use case, user, care pathway, technology, geography, and maturity.
- Build the landscape
Identify and classify relevant ventures, stakeholders, activity, relationships, and supporting market signals.
- Interpret the system
Assess clusters, influence, maturity, whitespace, dependencies, and the forces shaping ecosystem development.
- Prioritise action
Turn the map into target segments, organisations, partners, risks, and questions for deeper evaluation.
Related case studies
How Galen Growth has supported these decisions
Sourcing Digital Health for non-fluid underwriting
A global re-insurer wanted to identify mature ventures across non-fluid underwriting, digital biomarkers, digital therapeutics, genomics and teleconsultation
Competitive analysis in genomics for a reinsurance company
The Corporate Venture Capital (CVC) arm of a global reinsurance company wanted to, as part of their ongoing due diligence, undertake a global competitive analysis in the genomics space before committing to their selected investment target.
Macro and micro-environment analysis in RWD & RWE
The Corporate Venture Capital (CVC) arm of a global pharmaceutical company wanted to analyse a specific key APAC market to assess both the macro and micro-environment for Real World Data and Real Word Evidence to inform corporate strategy and prioritise key ventures for further engagement. By utilising Galen Growth's proven PlayBook methodology, we enabled our client to fully understand the RWD and RWE innovation environment and readiness to enable the identification and prioritisation of Digital Health ventures with the right capabilities and achievements. Further prioritisation driven by Deep Dive analysis of select ventures, to map their operating model, leading to direct engagement with their leadership team. The examination covered 1 key therapeutic area in 1 key APAC country. We screened 15 ventures and, in collaboration with our client, shortlisted 7.
Shortlisting personal health ventures in key therapeutic areas
A global leading medical device company sought to understand the personal health Digital Health landscape for two priority therapeutic areas in key global ecosystems to identify and evaluate relevant ventures
Related research
Evidence behind the market
Sectors
Designed for healthcare decisions
- Biopharma
- Medical device
- Health systems
- Insurance
- Investors
- Public-sector innovation
FAQ
Common questions
What is digital health ecosystem mapping?
It is the structured analysis of the companies, stakeholders, relationships, categories, evidence, and market signals that shape a defined digital health landscape.
How is an ecosystem map different from a company list?
A company list identifies participants. An ecosystem map also explains segmentation, relationships, maturity, momentum, gaps, and relevance to a specific decision.
Can the landscape be defined around a therapeutic area?
Yes. It can be scoped by therapeutic area, care pathway, problem statement, technology, market, customer group, or a combination of those lenses.
Related capabilities
Explore other decision areas
Your decision context
Bring us the question that needs a defensible answer.
We will help define the evidence, scope, and practical route from analysis to action.